Growth Metrics

Solid Biosciences (SLDB) Amortizatization of Intangibles (2017 - 2026)

Quarterly results put Amortizatization of Intangibles at $619000.0 for Q1 2026, up 98.4% from a year ago — trailing twelve months through Mar 2026 was $2.2 million (down 35.17% YoY), and the annual figure for FY2025 was $1.9 million, down 47.83%.

Solid Biosciences has reported Amortizatization of Intangibles over the past 10 years, most recently at $619000.0 for Q1 2026.

  • Amortizatization of Intangibles reached $619000.0 in Q1 2026 per SLDB's latest filing, down from $747000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $1.2 million in Q3 2024 and bottomed at -$371000.0 in Q1 2022.
  • Median Amortizatization of Intangibles over the past 5 years was $488000.0 (2025), compared with a mean of $485882.4.
  • The largest annual shift saw Amortizatization of Intangibles skyrocketed 5688.24% in 2023 before it tumbled 72.93% in 2025.
  • Over 5 years, Amortizatization of Intangibles stood at $276000.0 in 2022, then skyrocketed by 317.03% to $1.2 million in 2023, then tumbled by 30.23% to $803000.0 in 2024, then dropped by 6.97% to $747000.0 in 2025, then decreased by 17.14% to $619000.0 in 2026.
  • Business Quant data shows Amortizatization of Intangibles for SLDB at $619000.0 in Q1 2026, $747000.0 in Q4 2025, and $327000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 13,267.00
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn -
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn -
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn -
10 Solid Biosciences 713.77 Mn 333.09 Mn - 619,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 619,000.00
Mar 31, 2026 619,000.00
Dec 31, 2025 747,000.00
Dec 31, 2025 747,000.00
Sep 30, 2025 327,000.00
Sep 30, 2025 327,000.00
Jun 30, 2025 488,000.00
Jun 30, 2025 488,000.00
Mar 31, 2025 312,000.00
Mar 31, 2025 312,000.00
Dec 31, 2024 803,000.00
Dec 31, 2024 803,000.00
Sep 30, 2024 1.21 Mn
Sep 30, 2024 1.21 Mn
Jun 30, 2024 1.04 Mn
Jun 30, 2024 1.04 Mn
Mar 31, 2024 540,000.00
Mar 31, 2024 540,000.00
Dec 31, 2023 1.15 Mn
Dec 31, 2023 1.15 Mn
Sep 30, 2023 984,000.00
Sep 30, 2023 984,000.00
Jun 30, 2023 58,000.00
Jun 30, 2023 58,000.00
Mar 31, 2023 215,000.00
Mar 31, 2023 215,000.00
Dec 31, 2022 276,000.00
Dec 31, 2022 276,000.00
Sep 30, 2022 17,000.00
Sep 30, 2022 17,000.00
Jun 30, 2022 -155,000.00
Jun 30, 2022 -155,000.00
Mar 31, 2022 -371,000.00
Mar 31, 2022 -371,000.00
Dec 31, 2021 -582,000.00
Dec 31, 2021 -582,000.00
Sep 30, 2021 -528,000.00
Sep 30, 2021 -528,000.00
Jun 30, 2020 -1,000.00
Jun 30, 2020 -1,000.00
Mar 31, 2020 21,000.00
Mar 31, 2020 21,000.00
Dec 31, 2019 33,000.00
Dec 31, 2019 33,000.00
Sep 30, 2019 11,000.00
Sep 30, 2019 11,000.00
Jun 30, 2019 87,000.00
Jun 30, 2019 87,000.00
Mar 31, 2019 148,000.00
Mar 31, 2019 148,000.00
Dec 31, 2018 38,000.00
Dec 31, 2018 38,000.00
Sep 30, 2018 18,000.00
Sep 30, 2018 18,000.00
Jun 30, 2018 39,000.00
Jun 30, 2018 39,000.00
Mar 31, 2018 -5,000.00
Mar 31, 2018 -5,000.00
Dec 31, 2017 -12,000.00
Dec 31, 2017 -12,000.00
Sep 30, 2017 -31,000.00
Sep 30, 2017 -31,000.00
Jun 30, 2017 -56,000.00
Jun 30, 2017 -56,000.00
Mar 31, 2017 -107,000.00
Mar 31, 2017 -107,000.00